Pharmaceutical Policy

Improving the Quality, Safety and Efficiency of Medication Use

While prescription drugs are used by 80% of Americans, the improper, often unsafe use of medications leads to billions of dollars of avoidable healthcare costs. The goal of the CP3 research program is to improve patient and prescriber decision-making, and inform the regulation and coverage of pharmaceuticals. More >

Highlights

Addressing the Opioid Epidemic

In a commentary in JAMA Internal Medicine, Dr. Walid Gellad discusses the opioid epidemic within the Nation's Veteran population. 

Drug Shortages in the US

Each year the United States experiences a shortage of over 100 drugs. In an editorial in JAMA, Drs. Donohue and Angus explore the reasons. 

Safety Implications for Veterans

Expanding veterans' access to providers outside of the VA may increase the risk for unsafe prescribing practices, particularly in persons with dementia. Read more.

Changes in Hepatits C Drug Coverage

What type of impacts can be expected if state Medicaid programs limit treatment coverage to those with advanced Hepatitis C? Read more.

Lock-in programs

Dr. Gellad co-authored an editorial in the American Journal of Public Health outlining the history of lock-in programs to address prescription opioid abuse and why these programs may not be as beneficial in Medicare. Read more.

Buprenorphine in PA Medicaid

Several research projects at CP3 examine buprenorphine use for substance use disorder in Pennsylvania Medicaid. Read more.

1
2
3
4
5
6